II
DGX icon

IFM Investors’s Quest Diagnostics DGX Stock Holding History

IFM Investors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.71M Buy
26,937
+3,160
+13% +$620K 0.04% 387
2026
Q1 		$4.66M Buy
23,777
+196
+0.8% +$38.1K 0.04% 390
2025
Q4 		$4.09M Hold
23,581
– – 0.03% 409
2025
Q3 		$4.46M Buy
23,581
+170
+0.7% +$30.2K 0.04% 375
2025
Q2 		$4.21M Buy
23,411
+1,676
+8% +$291K 0.04% 377
2025
Q1 		$3.68M Buy
21,735
+880
+4% +$145K 0.04% 394
2024
Q4 		$3.15M Sell
20,855
-1,505
-7% -$234K 0.03% 442
2024
Q3 		$3.47M Sell
22,360
-1,531
-6% -$229K 0.03% 438
2024
Q2 		$3.27M Hold
23,891
– – 0.03% 437
2024
Q1 		$3.18M Hold
23,891
– – 0.03% 441
2023
Q4 		$3.29M Sell
23,891
-1,219
-5% -$160K 0.04% 400
2023
Q3 		$3.06M Buy
25,110
+2,025
+9% +$270K 0.04% 414
2023
Q2 		$3.24M Sell
23,085
-988
-4% -$136K 0.04% 402
2023
Q1 		$3.41M Buy
24,073
+380
+2% +$54.4K 0.05% 358
2022
Q4 		$3.71M Buy
23,693
+2,926
+14% +$420K 0.06% 324
2022
Q3 		$2.55M Hold
20,767
– – 0.05% 375
2022
Q2 		$2.76M Sell
20,767
-76
-0.4% -$10.4K 0.05% 368
2022
Q1 		$2.85M Buy
20,843
+3,405
+20% +$475K 0.04% 390
2021
Q4 		$3.02M Sell
17,438
-575
-3% -$87.5K 0.06% 339
2021
Q3 		$2.62M Hold
18,013
– – 0.05% 358
2021
Q2 		$2.38M Buy
18,013
+3,780
+27% +$495K 0.05% 402
2021
Q1 		$1.83M Buy
14,233
+1,340
+10% +$165K 0.05% 385
2020
Q4 		$1.54M Buy
12,893
+1,773
+16% +$216K 0.05% 373
2020
Q3 		$1.27M Buy
11,120
+1,177
+12% +$139K 0.05% 330
2020
Q2 		$1.13M Sell
9,943
-3,928
-28% -$417K 0.06% 322
2020
Q1 		$1.15M Sell
13,871
-566
-4% -$58.6K 0.05% 348
2019
Q4 		$1.54M Sell
14,437
-670
-4% -$69.9K 0.05% 352
2019
Q3 		$1.62M Buy
15,107
+5,938
+65% +$610K 0.06% 334
2019
Q2 		$933K Hold
9,169
– – 0.05% 376
2019
Q1 		$824K Buy
9,169
+1,257
+16% +$109K 0.05% 375
2018
Q4 		$659K Buy
7,912
+519
+7% +$48.7K 0.05% 365
2018
Q3 		$798K Buy
7,393
+882
+14% +$96.7K 0.06% 340
2018
Q2 		$716K Buy
6,511
+1,900
+41% +$198K 0.07% 311
2018
Q1 		$462K Buy
4,611
+273
+6% +$28K 0.07% 335
2017
Q4 		$427K Hold
4,338
– – 0.07% 340
2017
Q3 		$406K Buy
4,338
+298
+7% +$31.6K 0.07% 341
2017
Q2 		$449K Buy
4,040
+992
+33% +$105K 0.08% 295
2017
Q1 		$299K Buy
+3,048
New +$291K 0.08% 314

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

IFM Investors's DGX Position: Q2 2026 in Review

IFM Investors increased its Quest Diagnostics (DGX) stake by 13% in Q2 2026, buying an estimated $620K and bringing the position to 26,937 shares worth $5.71M. The position accounts for 0.04% of the portfolio, ranked #387.

IFM Investors first reported a position in DGX in Q1 2017 and has held it in 38 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • IFM Investors held 26,937 shares of Quest Diagnostics worth $5.71M as of Q2 2026.
  • IFM Investors bought 3,160 Quest Diagnostics shares in Q2 2026, an estimated $620K.
  • Quest Diagnostics made up 0.04% of IFM Investors's portfolio in Q2 2026, its #387 holding.
  • IFM Investors first reported a position in Quest Diagnostics in Q1 2017 and has held it in 38 quarters since.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.